Literature DB >> 3945889

Differentiation of pyogenic from amebic hepatic abscesses.

R L Conter, H A Pitt, R K Tompkins, W P Longmire.   

Abstract

Recent immigration trends have resulted in an increased prevalence of amebic hepatic abscesses in southern states and in many northern American cities. Because amebic hepatic abscesses generally do not require drainage, differentiation from pyogenic hepatic abscesses is important. We, therefore, reviewed the records of patients admitted to the UCLA Medical Center from 1968 through 1983 to compare the clinical manifestations and to access the results of treatment of pyogenic and amebic hepatic abscesses. During this 15 year period, 82 patients (42 pyogenic and 40 amebic) with hepatic abscesses were admitted. Factors which distinguished patients with pyogenic abscesses included: age greater than 50 years; jaundice; pruritus; sepsis and shock; a palpable mass; elevated bilirubin level; elevated alkaline phosphatase level, and abnormal abdominal roentgenograms. Patients with amebic abscesses of the liver were more likely to have Mexican ancestry, recently traveled to an endemic area, abdominal pain, diarrhea, abdominal tenderness, hepatomegaly and positive amebic serology. Hepatic scans and ultrasonography were excellent methods of detecting the presence of but not the type of hepatic abscess. Over-all, the mortality was 40 per cent for patients with pyogenic abscesses whereas all 40 of the patients with an amebic abscess survived. However, operative mortality was only 4.5 per cent for the 22 patients with pyogenic abscess who were managed with systemic antibiotics and surgical drainage. We conclude that many clinical and laboratory parameters can aid in the differentiation and, as a result, management of patients with pyogenic and amebic hepatic abscesses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945889

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  9 in total

1.  Clinical significance and mechanism of gas formation of pyogenic liver abscess due to Klebsiella pneumoniae.

Authors:  Hsin-Ling Lee; Hsin-Chun Lee; How-Ran Guo; Wen-Chien Ko; Kuan-Wen Chen
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

Review 2.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  Hepatic abscess.

Authors:  A J Donovan; A E Yellin; P W Ralls
Journal:  World J Surg       Date:  1991 Mar-Apr       Impact factor: 3.352

Review 4.  Clinical features and management of amebic liver abscess. Experience from 29 patients.

Authors:  T Weinke; W Scherer; U Neuber; M Trautmann
Journal:  Klin Wochenschr       Date:  1989-04-17

5.  Pyogenic liver abscess: multivariate analysis of risk factors.

Authors:  K T Lee; P C Sheen; J S Chen; C G Ker
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

Review 6.  Surgical management of hepatic abscesses.

Authors:  H A Pitt
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

7.  Pyogenic liver abscess: studies of therapy and analysis of risk factors.

Authors:  H J Mischinger; H Hauser; H Rabl; F Quehenberger; G Werkgartner; R Rubin; E Deu
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

8.  Predictive factors for early aspiration in liver abscess.

Authors:  Rustam Khan; Saeed Hamid; Shahab Abid; Wasim Jafri; Zaigham Abbas; Mohammed Islam; Hasnain Shah; Shaalan Beg
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

9.  Successful surgical drainage with intraoperative ultrasonography for amebic liver abscess refractory to metronidazole and percutaneous drainage: a case report.

Authors:  Keita Kouzu; Takahiro Einama; Makoto Nishikawa; Makiko Fukumura; Hiromi Nagata; Toshimitsu Iwasaki; Yoichi Miyata; Yasuhiro Obuchi; Kazuo Hase; Hideki Ueno; Yoji Kishi; Junji Yamamoto
Journal:  BMC Surg       Date:  2020-05-24       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.